Ernsberger P, Zhou J, Damon T H, Douglas J G
Department of Medicine, Case Western Reserve School of Medicine, Cleveland, Ohio 44106.
Am J Physiol. 1992 Sep;263(3 Pt 2):F411-6. doi: 10.1152/ajprenal.1992.263.3.F411.
The selective angiotensin (ANG II) antagonists losartan (DuP 753) and PD 123319 have been shown to bind selectively to AT1 and AT2 subtypes, respectively. To characterize ANG II receptor subtypes in mesangial cells, washed membranes were incubated with 0.1 to 0.5 nM 125I-ANG II and increasing concentrations of competitors. The inhibition of 125I-ANG II binding by losartan and PD 123319 was biphasic, and LIGAND curve-fitting analysis revealed two populations of specific binding sites. One subpopulation comprised 86% of the total and showed high affinity for ANG II and losartan, but low affinity for the AT2 antagonists PD 123319 and CGP42112A, and thus appear identical to the recently cloned AT1 subtype. The remaining 14% of the sites showed nearly 100-fold lower affinity for losartan and 10,000-fold higher affinity for PD 123319 relative to AT1 sites. However, another AT2-selective antagonist, CGP42112A, showed little affinity for these sites. Both classes of binding sites were inhibited by guanosine 5'-O-(3-thiophosphate) and pertussis toxin treatment. We propose that there are two distinct G protein-coupled ANG II receptor subtypes (AT1A and AT1B) present in renal mesangial cells.
选择性血管紧张素(ANG II)拮抗剂氯沙坦(DuP 753)和PD 123319已分别被证明可选择性地与AT1和AT2亚型结合。为了鉴定系膜细胞中的ANG II受体亚型,将洗涤过的细胞膜与0.1至0.5 nM的125I-ANG II以及浓度递增的竞争者一起孵育。氯沙坦和PD 123319对125I-ANG II结合的抑制呈双相性,并且LIGAND曲线拟合分析揭示了两个特异性结合位点群体。一个亚群占总数的86%,对ANG II和氯沙坦具有高亲和力,但对AT2拮抗剂PD 123319和CGP42112A具有低亲和力,因此似乎与最近克隆的AT1亚型相同。相对于AT1位点,其余14%的位点对氯沙坦的亲和力低近100倍,对PD 123319的亲和力高10,000倍。然而,另一种AT2选择性拮抗剂CGP42112A对这些位点几乎没有亲和力。两类结合位点均被鸟苷5'-O-(3-硫代磷酸酯)和百日咳毒素处理所抑制。我们提出,肾系膜细胞中存在两种不同的G蛋白偶联ANG II受体亚型(AT1A和AT1B)。